Lyra Therapeutics Inc Capital Reinvestment Ratio

Latest as of June 2021: 0.18x

Lyra Therapeutics Inc capital reinvestment ratio. Lyra Therapeutics Inc (LYRA) has a Capital Reinvestment Ratio of 0.18x as of June 2021, meaning it reinvests 0% of its operating cash flow ($3.38 Million) in capital expenditures ($625.00K). Check LYRA total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.18x

Capex / Operating Cash Flow

Operating Cash Flow

$3.38 Million

USD

Capital Expenditures

$625.00K

USD

Data as of

Jun 2021

Most recent filing

Lyra Therapeutics Inc Capital Reinvestment Ratio by Year (None–None)

Lyra Therapeutics Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see LYRA cash flow conversion.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow